
Discover Oncology, Journal Year: 2025, Volume and Issue: 16(1)
Published: March 20, 2025
Recently, there has been an increasing interest in investigating the potential benefits or risks associated with using immunosuppressants for treating specific tumors post organ transplantation, a focus on selecting appropriate drugs, doses, and treatment protocols. This study used bibliometric analysis to evaluate research trends hotspots this field. A systematic search was conducted Web of Science identify studies focusing cancer following transplantation from 2001 2023. The strategy utilized variety keywords including "immunosuppressants", "cancer" "transplant". Data extraction involved recording various parameters such as title, author, institution, country, publication, citation, H-index, immunosuppressant, type transplantation. encompassed total 94 studies. findings revealed that period 2005 2010 emerged most influential timeframe within research. United States ranked highest number publications, Vivarelli M identified productive University Bologna recognized institute. "Immunosuppression", "rapamycin" "kidney" were key Notably, rapamycin predominant immunosuppressant kidney prominent While have extensively transplant procedures, certain not well addressed. Further long-term monitoring are required numerous elucidate precise applications implications solid-organ recipients.
Language: Английский